An Investigator-initiated Trial to Assess the Effectiveness of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children
An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children
1 other identifier
interventional
48
1 country
1
Brief Summary
An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children. A sufficient number (maximum of 48, (16 children/arm)) of children subjects will be recruited to ensure a total of 45 subjects (15 children /arm) complete the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2023
CompletedFirst Posted
Study publicly available on registry
March 20, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 6, 2023
CompletedNovember 9, 2023
November 1, 2023
1 month
March 7, 2023
November 7, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Assessment of Safety
To evaluate the Safety of Test Product by using subject perception questionnaires regarding Health
Day 01 before test product usage to 30 Day after Test product usage
Assessment of Efficacy
To evaluate the Efficacy of Test Product by using subject perception questionnaires regarding Health
Day 01 before test product usage to 30 Day after Test product usage
Assessment of Organoleptic properties
To evaluate the Organoleptic properties of Test Product by using subject perception questionnaires regarding Test Product
30 Day after usage of Test product
Study Arms (3)
Curcumin Gummies
EXPERIMENTALCurcumin Gummies contain energy, dietary fiber, sugar, total carbohydrate, protein, fat, and curcumin.
Vitamin C Gummies
EXPERIMENTALVitamin C Gummies contain Vitamin C and Zinc
Multivitamin Gummies
EXPERIMENTALMultivitamin Gummies contain energy, dietary fiber, sugar, total carbohydrate, protein, fat, sodium, Vitamin C, Vitamin E, pantothenic acid, Zinc, iodine, Vitamin A, Magnesium, Folate, Vitamin D, Vitamin 12
Interventions
Chew gummies thoroughly and completely before swallowing.
Chew gummies thoroughly and completely before swallowing.
Chew gummies thoroughly and completely before swallowing.
Eligibility Criteria
You may qualify if:
- Age: 02 to 12 years old (both inclusive) at the time of parental consent.
- Overall good health of the child subject is determined by medical examination and history evaluated by the Investigator.
- Subject's mother/legal guardian, preferably willing to give a voluntary written informed consent i.e. parental informed consent form and agree to complete study activities and come for regular follow-up with a subject.
- The subject's mother/legal guardian for their child is preferably willing to abide by and comply with the study protocol.
- The subject should not participate in any other clinical study during participation in the current study
- Subject are agreed to maintain current level of activity through the study.
You may not qualify if:
- Subjects with known history of allergies or specific allergic reactions upon using curcumin, vitamins, zinc, pantothenic acid.
- Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment.
- Subjects, who in the opinion of the Investigator or the Expert physician are not eligible for enrolment in the study.
- Subject who are unwilling to provide consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NovoBliss Research Pvt Ltd
Gandhinagar, Gujarat, 382421, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dr. Chitra Prajapati, MBBS
Principal Investigator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This Study is Open-label
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 7, 2023
First Posted
March 20, 2023
Study Start
May 1, 2023
Primary Completion
June 1, 2023
Study Completion
July 6, 2023
Last Updated
November 9, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share